First Time Loading...

BioPlus Acquisition Corp
NASDAQ:BIOS

Watchlist Manager
BioPlus Acquisition Corp Logo
BioPlus Acquisition Corp
NASDAQ:BIOS
Watchlist
Price: 10.795 USD Market Closed
Updated: May 5, 2024
Section:
 

Wall Street
Price Targets

BIOS Price Targets Summary
BioPlus Acquisition Corp

Wall Street analysts forecast BIOS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BIOS is 20 USD .

BIOS Lowest Forecast
Wall Street Target
Not Available
BIOS Average Forecast
Wall Street Target
20 USD
85% Upside
BIOS Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
20 USD
85% Upside
Highest
Price Target
Not Available
BioPlus Acquisition Corp Competitors:
Price Targets
IHR
Impact Healthcare REIT PLC
37% Upside
CDRO
Codere Online US Corp
53% Upside
NAAS
Naas Technology Inc
406% Upside
CCAP
Crescent Capital BDC Inc
5% Upside
IHR
Impact Healthcare REIT PLC
37% Upside
CDRO
Codere Online US Corp
53% Upside
NAAS
Naas Technology Inc
406% Upside
CCAP
Crescent Capital BDC Inc
5% Upside
SLRC
SLR Investment Corp
3% Upside
M
MFIC
MidCap Financial Investment Corp
1% Upside
GAIN
Gladstone Investment Corp
2% Downside

Revenue
Forecast

Revenue Estimate
BioPlus Acquisition Corp

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
BioPlus Acquisition Corp

Operating Income forecast
is not available for
BioPlus Acquisition Corp

Net Income
Forecast

Net Income Estimate
BioPlus Acquisition Corp

Net Income forecast
is not available for
BioPlus Acquisition Corp

See Also

Summary
BIOS intrinsic value, competitors valuation, and company profile.
DCF Valuation
BIOS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BIOS stock valuation using valuation multiples.
Wall Street Estimates
BIOS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BIOS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BIOS's stock price target?
Price Target
20 USD

According to Wall Street analysts, the average 1-year price target for BIOS is 20 USD .

ALPHA SPREAD
Join more than 134,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.